Citations

Clear

98 citation(s) found for "Sharaf, I".

EPPOCRATIS: Expedited Preoperative Point-of-Care Reduction of Fractures to Normalized Anatomy and Three-Dimensional Printing to Improve Surgical Outcomes
Sharaf, Basel, Kuruoglu, Doga, Cantwell, Sean R., Alexander, Amy E., Dickens, Hunter J., Morris, Jonathan M., Sharaf, Basel , Sharaf, Basel A , Kuruoglu, Doga, Cantwell, Sean R., Alexander, Amy E., Dickens, Hunter J., Morris, Jonathan M.

Mayo Clinic

Plastic & Reconstructive Surgery | February 23, 2022 | Volume: 149 | Issue: 3 | Pages: 695-699

10.1097/prs.0000000000008871 | PMID 35196689 Get It

Summary: Virtual surgical planning and three-dimensional printing have been invaluable tools in craniomaxillofacial surgery. From planning head and neck reconstruction to orthognathic surgery and secondary reconstruction of maxillofacial trauma, virtual surgical planning and three-dimensional printing allow the surgeon to rehearse the surgical plan and use patient-specific surgical guides for carrying out the plan accurately. However, the process of virtual surgical planning and three-dimensional printing requires time and coordination between the surgeon on one hand and the biomedical engineers and designers on the other hand. Outsourcing to third-party companies contributes to inefficiencies in this process. Advances in surgical planning software and three-dimensional printing technology have enabled the integration of virtual surgical planning and three-dimensional printing at the treating hospital, the point of care. This allows for expedited use of this process in semiurgent surgical cases and acute facial trauma cases by bringing the surgeon, radiologist, biomedical engineers, and designers to the point of care. In this article, the authors present the utility of EPPOCRATIS, expedited preoperative point of care reduction of fractures to normalized anatomy and three-dimensional printing to improve surgical outcomes, in the management of acute facial trauma.
Sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement: Insights from the National Readmissions Database
Elbadawi, Ayman , Tan, Bryan E‐Xin , Saad, Marwan , Sharaf, Barry L., Gordon, Paul , Saad, Marwan , Tan, Bryan E-Xin , Sammour, Yasser M. , Omer, Mohamed , Baron, Suzanne J. , Abbott, J. Dawn

Mayo Clinic

Catheterization and Cardiovascular Interventions | February 8, 2022 | Volume: 99 | Issue: 5 | Pages: 1636-1644

10.1002/ccd.30072 | PMID 35132765 Get It

AbstractBackgroundThere is a paucity of data regarding the sex‐related differences in the trends and outcomes of trans‐septal transcatheter mitral valve replacement (TS‐TMVR).MethodsThe Nationwide Readmissions Database (2015–2018) was queried for admissions for TS‐TMVR. Propensity matched analysis was conducted to compare outcomes with hospitalizations for TS‐TMVR among women versus men. The main study outcome was in‐hospital mortality.ResultsOur final analysis included 2063 hospitalizations for TS‐TMVR; of whom, 58.1% were women. The proportion of women among those undergoing TS‐TMVR increased from 50% in 2015 to 60.2% in 2018 (Ptrend = 0.04). Compared with men, women undergoing TS‐TMVR were slightly younger, and had a distinct profile of comorbidities. After matching, there was no significant difference in in‐hospital mortality among women versus men undergoing TS‐TMVR (7.8% vs. 6.1%, OR = 1.30; 95% CI: 0.79–2.13). Subgroup analyzes showed an interaction toward higher mortality with women versus men among patients with CKD (Pinteraction = 0.07). There were no significant differences between women and men in in‐hospital complications or length of stay after TS‐TMVR. Compared with men, women undergoing TS‐TMVR were more likely to be discharged to a nursing facility (17.7% vs. 11.5%, p = 0.01) and had higher rates of 30‐day readmissions (22.4% vs. 13.6%, p = 0.01).ConclusionThis nationwide analysis showed an increase in the proportion of women among patients undergoing TS‐TMVR during the study years. There were no differences in in‐hospital mortality, in‐hospital complications, or length of stay between both sexes following TS‐TMVR. Women were more likely to be discharged to nursing facilities and had higher rates of readmission at 30 days even after propensity matching.
Abdominal Panniculectomy: An Analysis of Outcomes in 238 Consecutive Patients over 10 Years
Salinas, Cristina A., Tran, Nho V. , Nguyen, Minh-Doan T. , Martinez‐Jorge, Jorys, Bite, Uldis, Harless, Christin A., Sharaf, Basel , Martinez-Jorge, Jorys, Sharaf, Basel A , Kuruoglu, Doga

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | February 1, 2022 | Volume: 9 | Issue: 11 | Pages: e3955

10.1097/gox.0000000000003955 | PMID 34840922 Get It

Background: Panniculectomy is a commonly performed body contouring procedure to address skin laxity and its related complications. This study aimed to assess clinical outcomes of abdominal panniculectomy and identify predictors of complications at a tertiary academic healthcare center. Methods: A retrospective review of patients who underwent panniculectomy between January 2010 and January 2020 at our institution was performed. Exclusion criteria were a history of prior panniculectomy or abdominoplasty. Patient characteristics and clinical outcomes were collected. Univariate and multivariable analyses were performed to assess the risk factors of complications. Results: The mean age in the included 238 patients was 51.7 ± 12.7 years, and the mean body mass index (BMI) at the time of panniculectomy was 33 ± 7.5 kg/m 2 . Median resection weight was 2.7 kg (range: 0.15–14.6) and median length of hospital stay was 2 days (range: 0–24). Mean follow-up time was 50 ± 37 months. The rate of major complications was 22.3%. Revision surgery was performed in 3.4% of the cases. Multivariable analyses demonstrated that increase in BMI ( P = 0.007) and active smoking ( P = 0.026) were significantly associated with increased odds of major complication, and increase in BMI ( P = 0.0004), history of venous thromboembolism ( P = 0.034) and having a concomitant ventral hernia repair ( P = 0.0044) were significantly associated with having a length of hospital stay of 3 days or more. Conclusions: Panniculectomy is generally safe to perform, with major postoperative complication rate of 22.3% in our series. Increase in BMI and active smoking were significantly associated with having a major complication. Higher BMI, concomitant hernia repair, and a history of venous thromboembolism were associated with length of hospital stay of 3 days or more.
Efficacy of Tranexamic Acid in Reducing Seroma and Hematoma Formation Following Reduction Mammaplasty
Weissler, Jason M., Antezana, Luis A. , Curiel, Daniel , Kerivan, Lauren, Alsayed, Ahmed , Banuelos, Joseph, Harless, Christin A., Sharaf, Basel , Vijayasekaran, Aparna , Martinez‐Jorge, Jorys, Tran, Nho V. , Nguyen, Minh-Doan T. , Antezana, Luis , Sharaf, Basel A, Martinez-Jorge, Jorys, Sharaf, Basel A , Kuruoglu, Doga

Mayo Clinic

Aesthetic Surgery Journal | January 14, 2022 | Volume: 42 | Issue: 6 | Pages: 616-625

10.1093/asj/sjab399 | PMID 35029651 Get It

Abstract Background Tranexamic acid (TXA) has gained increasing recognition as a valuable pharmacologic agent within plastic surgery. Objectives The aim of this study was to investigate the value and safety profile of both intravenous and topically administered TXA in the setting of bilateral reduction mammaplasty. Methods A retrospective review was performed to identify consecutive patients who underwent bilateral reduction mammaplasty for symptomatic macromastia (January 2016-July 2021). Pertinent preoperative, intraoperative, and postoperative details were collected/reviewed. Primary outcome measures included hematoma requiring surgical evacuation and clinically significant/symptomatic seroma formation mandating percutaneous aspiration. Patients taking anticoagulation/antiplatelet medication or those with a history of thromboembolic diseases were excluded. Patients who had received TXA were compared to a historical control group who did not receive TXA within the same consecutive cohort. Results A total of 385 consecutive patients (770 breasts) were included. TXA was used in 514 (66.8%) cases (topical, 318 [61.9%]; intravenous, 170 [33.1%]; intravenous and topical, 26 [5.1%]). Neither seroma nor hematoma were impacted/reduced with TXA (P > 0.05). Increased age (hazards ratio, 1.06 per 1-year increase; 95% CI, 1.004-1.118) significantly increased the risk of hematoma (P = 0.032). The use of drains significantly decreased the risk of seroma (P < 0.0001). Increased BMI increased the risk of seroma (hazards ratio, 1.16 per 1-kg/m2 increase; 95% CI, 1.06-1.26; P = 0.0013). The use of TXA did not impact drain duration. Conclusions This study, the largest to date on the use of IV and topical TXA, did not find any reduction in risk when using TXA in breast reduction surgery. Level of Evidence: 3
EPPOCRATIS: A Point-of-Care Utilization of Virtual Surgical Planning and Three-Dimensional Printing for the Management of Acute Craniomaxillofacial Trauma
Sharaf, Basel , Kuruoglu, Doga , Sharaf, Basel A, Kuruoglu, Doga , Sharaf, Basel A , Morris, Jonathan M.

Mayo Clinic

Journal of Clinical Medicine | December 1, 2021 | Volume: 10 | Issue: 23 | Pages: 5640

10.3390/jcm10235640 | PMID 34884342 Get It

While virtual surgical planning (VSP) and three-dimensional planning (3DP) have become important tools in acute craniomaxillofacial surgery, the incorporation of point of care VSP and 3DP is crucial to allow for acute facial trauma care. In this article, we review our approach to acute craniomaxillofacial trauma management, EPPOCRATIS, and discuss current challenges and future directions in acute facial trauma management.
Point of Care Virtual Surgical Planning and Three-Dimensional Printing for Feminizing Foreheadplasty
Sharaf, Basel, Morris, Jonathan, Vyas, Krishna S., Vyas, Krishna S. , Sharaf, Basel , Sharaf, Basel A , Morris, Jonathan, Vyas, Krishna S.

Mayo Clinic

Plastic & Reconstructive Surgery | October 27, 2021 | Volume: 148 | Issue: 6 | Pages: 1080e-1082e

10.1097/prs.0000000000008575 | PMID 34705813 Get It

Initial Management of Orbital Trauma: Is an Ophthalmologic Evaluation Necessary?
Mullen, Barbara L., Yan, María , Mullen, Barbara , Wagner, Lilly H. , Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 23, 2021 | Volume: 9 | Issue: 10S | Pages: 67-68

10.1097/01.gox.0000799444.46576.b7 Get It

Upper Blepharoplasty with Concurrent Ptosis Correction: A Safe and Effective Procedure
Rodriguez, Liset Falcon , Bite, Uldis, Kuruoglu, Doga , Wagner, Lilly H. , Bradley, Elizabeth A. , Mardini, Samir , Sharaf, Basel

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | October 23, 2021 | Volume: 9 | Issue: 10S | Pages: 20-21

10.1097/01.gox.0000799188.60801.d2 Get It

Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma
Murugesan, Karthikeyan , Sharaf, Radwa , Montesion, Meagan , Moore, Jay A. , Pao, James , Pavlick, Dean C. , Upadhyay, Vivek , Alexander, Brian M. , Miller, Vincent A. , Javle, Milind , Bekaii‐Saab, Tanios , Albacker, Lee A. , Ali, Siraj M. , Bekaii Saab, Tanios S, Bekaii-Saab, Tanios S , Alexander, Brian M , Frampton, Garrett M. , Ross, Jeffrey S

Mayo Clinic

JCO Precision Oncology | August 19, 2021 | Volume: No volume available | Issue: 5 | Pages: 1285-1296

10.1200/po.20.00397 | PMID 34476330 Get It

PURPOSE Combined hepatocellular cholangiocarcinoma (cHCC-CCA) is a rare, aggressive primary liver carcinoma, with morphologic features of both hepatocellular carcinomas (HCC) and liver cholangiocarcinomas (CCA). METHODS The genomic profiles of 4,975 CCA, 1,470 HCC, and 73 cHCC-CCA cases arising from comprehensive genomic profiling in the course of clinical care were reviewed for genomic alterations (GA), tumor mutational burden, microsatellite instability status, genomic loss of heterozygosity, chromosomal aneuploidy, genomic ancestry, and hepatitis B virus status. RESULTS In cHCC-CCA, GA were most common in TP53 (65.8%), TERT (49.3%), and PTEN (9.6%), and 24.6% cHCC-CCA harbored potentially targetable GA. Other GA were predominantly associated with either HCC or CCA, including, but not limited to, TERT, FGFR2, IDH1, and presence of hepatitis B virus. On the basis of these features, a machine learning (ML) model was trained to classify a cHCC-CCA case as CCA-like or HCC-like. Of cHCC-CCA cases, 16% (12/73) were ML-classified as CCA-like and 58% (42/73) cHCC-CCA were ML-classified as HCC-like. The ML model classified more than 70% of cHCC-CCA as CCA-like or HCC-like on the basis of genomic profiles, without additional clinico-pathologic input. CONCLUSION These findings demonstrate the use of ML for classification as based on a targeted exome panel used during routine clinical care. Classification of cHCC-CCA by genomic features alone creates insights into the biology of the disease and warrants further investigation for relevance to clinical care.
Paradoxical Temporal Enlargement: An Expansion of Superficial Temporal Fat Pad Following Interfacial Technique for Pterional Craniotomy
Krug, Randall G. , Yan, María , Kamath, Marielle J., Graffeo, Christopher S. , Sharaf, Basel , Sharaf, Basel A , Kuruoglu, Doga , Gompel, Jamie J. Van , Morris, Jonathan M.

Mayo Clinic

Journal of Craniofacial Surgery | June 29, 2021 | Volume: 32 | Issue: 8 | Pages: 2597-2602

10.1097/scs.0000000000007730 | PMID 34183631 Get It

Objective: Contour irregularities in the temporal region have been reported previously after procedures involving temporal dissection. In this study, we report paradoxical temporal enlargement (PTE) following interfascial pterional craniotomy. Methods: A retrospective review of patients who underwent a unilateral transcranial procedure with frontotemporal approach at our institution between September 2013 and December 2017 was performed. Patients with a previous craniotomy or bilateral craniotomy were excluded. Radiological imaging series including computed tomography and magnetic resonance imaging were utilized to calculate temporal soft tissue volumes both preoperatively and postoperatively by using advanced software technology. Relative soft tissue volume differences between the operative side and the contralateral side were calculated at different time-points including preoperative, 3-months follow-up (3M), 12-months (12M) follow-up, and the last follow-up (LFU, over 1-year). Results: Forty-three patients were included. Mean age was 52.7 ± 4.5 years. Mean follow-up was 27.9 ± 15.8 months. Significant changes of temporal fat pad relative-volume difference were observed between the preoperative and the corresponding 3M (t [82] = −2.8865, P = 0.0050); 12M (t [77] = −4.4321, P < 0.0001), and LFU (t [74] = −4.9862, P < 0.0001) postoperative time points. No significant change of the temporalis muscle was observed between the preoperative and the corresponding 3M (P = 0.3629), 12M (P = 0.1553), or LFU (P = 0.0715). Soft tissue volume showed a significant increase on the operative side between the preoperative and the corresponding LFU (t [74] = −2.5866, P = 0.0117). Conclusions: Paradoxical temporal enlargement with more than 10% volumetric change was observed in 24% of the patients at their LFU (>1-year). This change was not due to temporalis muscle changes. Paradoxical temporal enlargement was due to hypertrophy of the superficial temporal fat pad. Before surgical correction of postoperative temporal contour changes, it is important to obtain imaging and characterize the etiology of the deformity.